Anesthesia

Video Laryngoscopes Market 2020-2024 | Growing Partnerships to Boost Growth | Technavio

Retrieved on: 
Thursday, May 28, 2020

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40448

Key Points: 
  • To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40448
    Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
  • Our video laryngoscopes market report covers the following areas:
    This study identifies the shift in preference from conventional laryngoscopy methods as one of the prime reasons driving the video laryngoscopes market growth during the next few years.
  • Backed with competitive intelligence and benchmarking, our research reports on the Video Laryngoscopes Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

Frost & Sullivan Reveals Non-contact Patient Monitoring Technologies to Revolutionize Healthcare

Retrieved on: 
Wednesday, May 27, 2020

SANTA CLARA, California, May 27, 2020 /PRNewswire/ --Frost & Sullivan's recent analysis, Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring, reports that non-contact patient monitoring technologies are gravitating toward the use of video, sound analysis and mobile-based platforms.

Key Points: 
  • SANTA CLARA, California, May 27, 2020 /PRNewswire/ --Frost & Sullivan's recent analysis, Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring, reports that non-contact patient monitoring technologies are gravitating toward the use of video, sound analysis and mobile-based platforms.
  • Kauladded: "The current COVID-19 pandemic situation offers a huge opportunity for non-contact patient monitoring technologies as they facilitate the early detection of respiratory complications in suspected patients.
  • Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoringis part of Frost & Sullivan's global TechVision Growth Partnership Service program.
  • Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring

Frost & Sullivan Reveals Non-contact Patient Monitoring Technologies to Revolutionize Healthcare

Retrieved on: 
Wednesday, May 27, 2020

SANTA CLARA, Calif., May 27, 2020 /PRNewswire/ --Frost & Sullivan's recent analysis, Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring, reports that non-contact patient monitoring technologies are gravitating toward the use of video, sound analysis and mobile-based platforms.

Key Points: 
  • SANTA CLARA, Calif., May 27, 2020 /PRNewswire/ --Frost & Sullivan's recent analysis, Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring, reports that non-contact patient monitoring technologies are gravitating toward the use of video, sound analysis and mobile-based platforms.
  • Kauladded: "The current COVID-19 pandemic situation offers a huge opportunity for non-contact patient monitoring technologies as they facilitate the early detection of respiratory complications in suspected patients.
  • Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoringis part of Frost & Sullivan's global TechVision Growth Partnership Service program.
  • Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring

Masimo and Philips licensing agreement brings Masimo NomoLine® Capnography and O3® Regional Oximetry to select Philips patient monitors

Retrieved on: 
Wednesday, May 27, 2020

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions.

Key Points: 
  • Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions.
  • Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies [1].
  • [1] Published clinical studies on pulse oximetry and the benefits of Masimo SET can be found on our website at http://www.masimo.com .
  • These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo NomoLine, O3, SET, rainbow SET, and Root.

Masimo and Philips Licensing Agreement Brings Masimo NomoLine® Capnography and O3® Regional Oximetry to Select Philips Patient Monitors

Retrieved on: 
Wednesday, May 27, 2020

In 2016, Masimo and Philips entered into a multi-year business partnership involving both companies innovations in patient monitoring and therapy solutions.

Key Points: 
  • In 2016, Masimo and Philips entered into a multi-year business partnership involving both companies innovations in patient monitoring and therapy solutions.
  • Now, in 2020, Philips becomes one of Masimos first industry partners to launch additional advanced Masimo measurements, NomoLine and O3, in their own patient monitors, sharing Masimos expertise in capnography and regional cerebral oximetry with caregivers and patients around the world.
  • O3 regional oximetry may help clinicians monitor cerebral oxygenation in situations in which pulse oximetry alone may not be fully indicative of the oxygen in the brain.
  • The complementary strengths of Philips and Masimo allow us to offer, reliable ventilation and regional oximetry solutions, which we expect will help clinicians deliver even better patient care.

Sensor Patch Market by Product, Application, Wearable Type, End-user Industry and Region - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 27, 2020

The "Sensor Patch Market by Product (Temperature, Blood Glucose, Blood Pressure, Heart Rate, ECG, & Blood Oxygen), Application (Monitoring, Diagnostics), Wearable Type (Wristwear, Neckwear, Bodywear), End-user Industry, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sensor Patch Market by Product (Temperature, Blood Glucose, Blood Pressure, Heart Rate, ECG, & Blood Oxygen), Application (Monitoring, Diagnostics), Wearable Type (Wristwear, Neckwear, Bodywear), End-user Industry, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The growing adoption of telehealth and advancements in wearable solutions and digital technologies provide major opportunities for the growth of the sensor parch market.
  • North America is expected to hold the largest share of the sensor patch market during the forecast period.
  • The increasing R&D capabilities are broadening the application areas of sensor patches in fitness, and sports and healthcare industries.

North American Partners in Anesthesia provides anesthesia services at Monmouth Medical Center Southern Campus, expanding its clinical partnership with RWJBarnabas Health and New Jersey footprint

Retrieved on: 
Thursday, May 21, 2020

MELVILLE, N.Y., May 21, 2020 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, has expanded its clinical partnership with RWJBarnabas Health to provide anesthesia services at Monmouth Medical Center Southern Campus (Monmouth South), a fully accredited acute care hospital located in Lakewood, New Jersey.

Key Points: 
  • MELVILLE, N.Y., May 21, 2020 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, has expanded its clinical partnership with RWJBarnabas Health to provide anesthesia services at Monmouth Medical Center Southern Campus (Monmouth South), a fully accredited acute care hospital located in Lakewood, New Jersey.
  • Monmouth South and its sister hospital, Monmouth Medical Center in Long Branch, New Jersey, where NAPA has provided anesthesia for more than ten years, are affiliates of RWJBarnabas Health.
  • With this new relationship, NAPA continues to strengthen its presence in the Monmouth market as it grows its footprint in New Jersey.
  • As a clinician-led organization, North American Partners in Anesthesia is redefining healthcare, delivering unsurpassed excellence to its partners and patients every day.

Biovo Products in the Days of COVID-19

Retrieved on: 
Thursday, May 21, 2020

It requires practically no attention from the nurses after fast and simple initial setup, except from response to alarm indication.

Key Points: 
  • It requires practically no attention from the nurses after fast and simple initial setup, except from response to alarm indication.
  • Both products require training of first-time users, and Biovo has developed a remote on-line training program for use during the COVID-19 restrictions.
  • Pursuing its vision of safer surgery and intensive care, Biovo is continuing to develop its HyperFlex-LMlaryngeal mask for anesthesia.
  • Biovo develops, manufactures and markets worldwide devices that address unmet clinical needs in Intensive Care Units, Operating Rooms and Anesthesia markets.

VSMS ECG Patch receives US FDA 'Emergency Use Authorisation' for patients being treated for COVID-19

Retrieved on: 
Wednesday, May 20, 2020

CEODrYacov Geva said:"This authorisation from the FDA is an outstanding development for G Medical and its value cannot be underestimated.

Key Points: 
  • CEODrYacov Geva said:"This authorisation from the FDA is an outstanding development for G Medical and its value cannot be underestimated.
  • The Patch is part of the modular VSMS and is an easy-to-use, clinical grade solution used for monitoring patients through the healthcare lifecycle.
  • The Patch streamlines and simplifies healthcare and patient monitoring by delivering continuous, 14 day recording of 6 channel ECG.
  • G Medical also offers a professional real-time patient continuous monitoring solution, G Medical's Vital Signs Monitoring System (VSMS) and G Medical Patch (GMP).

AANA Partners with 47 Nursing Organizations to Remove Practice Barriers in the VA

Retrieved on: 
Tuesday, May 19, 2020

"Particularly during these unprecedented times, ensuring the health care of our veterans and patients across the country is crucial," cited the letter .

Key Points: 
  • "Particularly during these unprecedented times, ensuring the health care of our veterans and patients across the country is crucial," cited the letter .
  • As advanced practice nurses, CRNAs have vast experience in critical care settings and advanced education and training in anesthesiology.
  • The Centers for Medicare & Medicaid Services has already taken action to remove physician supervision requirements for CRNAs during the public health emergency.
  • Members of the Nursing Community Coalition are the cross section of stakeholders in education, practice, research, and regulation within the nursing profession and have long supported full practice authority for all Advanced Practice Registered Nurses (APRNs).